Fermenta Biotech Limited

(Fermenta/FBL)

Established in 1951, Fermenta is one of the largest manufacturers of Vitamin D3 and a key global player. Headquartered in Thane, India, Fermenta caters to clientele across the globe, with a worldwide distribution network. Its state-of-the-art R&D centre is based at Thane, and world class manufacturing facilities are located in Kullu, Himachal Pradesh and Dahej, Gujarat. Apart from Vitamin D3, Fermenta also offers niche APIs, integrated biotechnology platforms such as enzymes for antibiotic synthesis as well as environmental solutions for waste water management and treatment.

Fermenta��s Ethos

Enhancing shared value for all stakeholders through responsible business

Focusing on customer requirements through innovation-driven products

Striving for excellence through consistent and sustainable performance

Fostering inclusiveness and engagement amongst our human capital

Ensuring integrity and trust are at the core of our organization��s philosophy

Our Businesses

Vitamin D3 and other APIs

Fermenta is a leading manufacturer and global supplier of Vitamin D3.

Nutritional Premixes

Fermenta offers premix solutions for fortifying food, in order to enhance its nutritional content.

Biotechnology

Fermenta delivers proprietary specialised technologies through its enzyme portfolio across the biopharmaceutical

Environmental Solutions

Fermenta Biotech Limited offers a comprehensive set of solutions designed to sustainably

Real Estate

Fermenta entered the property development business in 2012, following the establishment of a state-of-the-art IT

News & Announcements

Fermenta in the news:

India��s Best Workplaces in Biotechnology & Pharmaceuticals 2021

Fermenta is one amongst just eight companies recognized as India��s Best Workplaces in Biotechnology & Pharmaceuticals. Fermenta has earned this recognition for creating a great workplace for all the employees and demonstrating its values in the five dimensions of building a High-Trust, High-Performance Culture �� - credibility, respect, fairness, pride, and camaraderie.

Click here

Fermenta develops and files patent applications(s) for synthesis of COVID-19 drug, Molnupiravir

Fermenta has successfully developed and filed patent application for enzymatic synthesis of Molnupiravir, an orally-active COVID-19 drug. This novel technology using green chemistry provides a sustainable, efficient and scalable method of manufacturing the drug.

Click here